Comerica Bank
ORIC icon

Comerica Bank’s Oric Pharmaceuticals ORIC Stock Holding History

Comerica Bank’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-294
Closed -$1.64K – 3774
2025
Q1 		$1.64K Buy
+294
New +$2.57K ﹤0.01% 3509
2024
Q1 		– Sell
-1,332
Closed -$12.3K – 3803
2023
Q4 		$12.3K Hold
1,332
– – ﹤0.01% 3109
2023
Q3 		$8.06K Buy
+1,332
New +$10.9K ﹤0.01% 3243

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Comerica Bank's ORIC Position: Q2 2025 in Review

Comerica Bank sold out of Oric Pharmaceuticals (ORIC) in Q2 2025, closing a stake of 294 shares — an estimated $1.64K sold.

Comerica Bank first reported a position in ORIC in Q3 2023 and held it in 3 quarters. The position peaked at $12.3K in Q4 2023. 142 funds tracked by Wall St. Rank hold ORIC as of Q2 2025.

  • Comerica Bank reported no remaining Oric Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Comerica Bank sold 294 Oric Pharmaceuticals shares in Q2 2025, an estimated $1.64K.
  • Comerica Bank first reported a position in Oric Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • Comerica Bank's Oric Pharmaceuticals position peaked at $12.3K in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2025.

Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.